Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-25-053094

Chief Strategy Officer sold 1,862 shares at $7.17 ($13,351)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Nayak Sanjay · Chief Strategy Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-05-23 Sale : show line 1 in the form 10b5-1 −1,862 $7.17 $13,351 281,623 D
Open-market sales · 1,862 sh · avg $7.17 · $13,351
Loading xslF345X05/tm2516174-4_4seq1.xml…